A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Rhinitis, Allergic, PerennialAllergic Rhinitis

Interventions

DRUG

Fluticasone propionate

Corticosteriod, with anti-inflammatory effects

DRUG

Placebo

Placebo comparator

Trial Locations (1)

GSK Investigational Site, Vienna